Asimov

Intelligent design of living systems

Boston, United States · Founded 2017 · $179.7M raised

Employees
11–50
Founded
2017
Business Model
SaaS
Website
asimov.com
Total Funding
$179.7M
Last Round
$175.0M Series BJan 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Asimov is a synthetic biology company based in Boston that builds an integrated platform of engineered GMP host cells, genetic parts libraries, and cloud-based design software to help biopharma companies design and manufacture biologics, cell therapies, gene therapies, and RNA therapies. Its CHO Edge, LV Edge, AAV Edge, and RNA Edge product lines combine genetic tools with data-driven models to raise production titers, and its design software lets customers design, simulate, and optimize genetic systems for their own applications.

Summary

Asimov is a Healthcare company based in Boston, United States, founded in 2017. It has raised $179.7M in total across 2 rounds, most recently a $175.0M Series B round in Jan 2023. Investors include Canada Pension Plan Investment Board and Andreessen Horowitz.

Tech & App Stack

12 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2023
$175.0M

Sign up to see all 2 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Asimov on Indexed.vc
<a href="https://indexed.vc/companies/asimov"><img src="https://indexed.vc/api/badge/company/asimov" alt="Asimov on Indexed.vc" width="260" height="76" /></a>